Pulmonx Corporation (LUNG) Financials

LUNG Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 114.7 million 75.5 million
March 31, 2026 120.0 million 74.2 million
Dec. 31, 2025 129.3 million 75.2 million
Sept. 30, 2025 138.3 million 78.2 million

LUNG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.2 million 3.7 million
March 31, 2026 -10.1 million 4.1 million
Dec. 31, 2025 -7.1 million 4.2 million
Sept. 30, 2025 -8.3 million 5.2 million

LUNG Net Income

No data available :(

LUNG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 55.8 million 54.8 million -
March 31, 2026 61.6 million 37.2 million 19.0 million
Dec. 31, 2025 70.0 million 37.0 million 18.1 million
Sept. 30, 2025 76.5 million 37.0 million 19.4 million

LUNG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 42.2 million
March 31, 2026 41.9 million
Dec. 31, 2025 41.4 million
Sept. 30, 2025 40.9 million

LUNG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1000 5.0 million 21.8 million -
March 31, 2026 9000 4.9 million 24.1 million -
Dec. 31, 2025 13000 4.6 million 22.9 million -
Sept. 30, 2025 89000 4.8 million 25.6 million -

LUNG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 22.8 million 5.0 million
March 31, 2026 20.6 million 4.5 million
Dec. 31, 2025 22.6 million 5.1 million
Sept. 30, 2025 21.5 million 5.5 million

LUNG

Price: $2.26

52 week price:
1.13
2.89

Earnings Per Share: -1.15 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 23949

Market Capitalization: 86.6 million

Links: